National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa

Sponsor
North-West University, South Africa (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05982847
Collaborator
Medical Research Council, South Africa (Other), University of Cape Town (Other), University of Limpopo (Other), Walter Sisulu University (Other), University of KwaZulu (Other), Red Cross War Memorial Childrens Hospital (Other), University of Witwatersrand, South Africa (Other), University of Zurich (Other), Groote Schuur Hospital (Other), Nelson Mandela Metropolitan University (Other), Chris Hani Baragwanath Academic Hospital (Other), University of the Free State (Other)
22,464
11
58
2042.2
35.2

Study Details

Study Description

Brief Summary

The Childhood Hypertension Consortium of South Africa (CHCSA) was established to foster relationships between the healthcare sector and schools through community engagement and outreach as well as contributing to the decolonization of normative paediatric blood pressure reference values. To date, there has been no nation-wide project in South Africa to determine nationally representative normal blood pressure reference values, nor to estimate the true prevalence of hypertension in the paediatric population of the country. This study will provide critical information on the understanding of blood pressure and hypertension in children, especially of African ancestry. Not only will this effort contribute to the development of the first nationally representative normal reference values of blood pressure but will also benefit healthcare providers in the sector with a clear guideline on the management of high blood pressure in children as developed by experts working with these challenges daily.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Blood pressure screening

Detailed Description

Rationale: Currently there exist no nationally representative set of normative reference values for blood pressure and anthropometry in South African children, while clinicians rely on European and US reference values. The latter seems inappropriate in the South African setting, especially considering the lack of data available in African ancestry normative data.

Objectives: The investigators aim to development the first nationally representative normal reference values of blood pressure and anthropometry in children, to develop scientific evidence-based hypertension guidelines in the paediatric population of South Africa.

Methods: The target population for this study includes 5 to under 18 years school-aged (all school quintiles) children in South Africa from all provinces in the country selected in a randomized manner and to ensure generalizability.

Population: A sample of 22 464 (81% Black African; 9% Coloured; 8% White and 2% Indian/Asian) will be required to enable computation of reference values for each age and sex across urban, peri-urban and rural settings in all provinces.

Time frame: The study will recruit and collect data over a period of five years.

Expected outcomes: The investigators expect that normative blood pressure in children (ages above 5 and under 18 years) will differ from currently accepted international thresholds. The investigators will engage in the communities to optimise awareness and care of high blood pressure and its comorbidities. Recommendations will be made to the National Department of Health regarding blood pressure measurement/screening for hypertension in children at the local clinic in the Road to Health booklet. The investigators will also develop the first clinical practice guidelines for the management of hypertension in children in South Africa in collaboration with hypertension societies.

Study Design

Study Type:
Observational
Anticipated Enrollment :
22464 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
National Blood Pressure Screening in Children to Optimise Clinical Management of Paediatric Hypertension in South Africa
Anticipated Study Start Date :
Feb 1, 2024
Anticipated Primary Completion Date :
Nov 30, 2028
Anticipated Study Completion Date :
Nov 30, 2028

Arms and Interventions

Arm Intervention/Treatment
Boys

Diagnostic Test: Blood pressure screening
Blood pressure and anthropometric measurements will be performed in children and adolescents between ages 5-18 years to develop South African nomograms that will aid in the development of clinical practice guidelines to optimise hypertension care in South Africa youth.
Other Names:
  • Anthropometric measurements
  • Girls

    Diagnostic Test: Blood pressure screening
    Blood pressure and anthropometric measurements will be performed in children and adolescents between ages 5-18 years to develop South African nomograms that will aid in the development of clinical practice guidelines to optimise hypertension care in South Africa youth.
    Other Names:
  • Anthropometric measurements
  • Outcome Measures

    Primary Outcome Measures

    1. To determine and compute nationally representative normative reference values for blood pressure in children [Through study completion, an average of 1 year]

      To date there are no national normative blood pressure reference values for children in South Africa. Normative values used by clinicians are those extrapolated from studies on blood pressure done in the USA and Europe and these may not be truly representative of normative values of blood pressure in South Africa. This study aims to address this issue, because children can be misdiagnosed for high blood pressure based on the wrong normative values.

    2. To determine and compute nationally representative normative reference values for blood pressure in children [Through study completion, an average of 1 year]

      Overweight and obesity classification according to the World Health Organisation percentiles for childhood obesity only include a small sample size from less than five African countries, therefore the underrepresentation of children of African ancestry will be addressed by this study.

    3. To develop clinical practice guidelines for the management of childhood hypertension in South Africa [Through study completion, an average of 1 year]

      The findings of this study will help develop clinically relevant guidelines for the management of hypertension in children between 5 and 18 years of age based on local normative values, as well as to improve cost and availability of anti-hypertensive agents for children and adolescents.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • All children between ages 5-<18 years

    • All children with voluntary assent/consent and parent's permission

    Exclusion Criteria:
    • circumstances interfere with the participant's ability to give informed consent (diminished understanding or comprehension, or any language barriers that may pose potential risk in participation under false expectations)

    • randomly selected children who choose not to participate (lack of assent/consent), even if parent's permission was received,

    • conditions that interfere with a patient's ability to follow study guidelines, e.g., the use of drugs, alcohol or tobacco products

    • ages >18 years or under 5 years

    • Children will be excluded from the analysis for the determination of normative reference values for blood pressure and anthropometry if taking certain concomitant medication(s) that may affect their blood pressure, or any underlying disease e.g., chronic kidney disease, chronic heart disease etc. that may raise blood pressure.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Walter Sisulu University Mthatha Eastern Cape South Africa
    2 Nelson Mandela Metropolitan University Port Elizabeth Eastern Cape South Africa
    3 University of the Free State Bloemfontein Free State South Africa
    4 University of the Witwatersrand Johannesburg Gauteng South Africa
    5 University of KwaZulu-Natal Durban KwaZulu-Natal South Africa
    6 University of Limpopo Polokwane Limpopo South Africa
    7 Hypertension in Africa Research Team (HART), North-West University Potchefstroom North West South Africa 2531
    8 Red Cross War Memorial Children Hospital Cape Town Western Cape South Africa
    9 South African Medical Research Council Cape Town Western Cape South Africa
    10 University of Cape Town Cape Town Western Cape South Africa
    11 University of Zurich Zürich Switzerland

    Sponsors and Collaborators

    • North-West University, South Africa
    • Medical Research Council, South Africa
    • University of Cape Town
    • University of Limpopo
    • Walter Sisulu University
    • University of KwaZulu
    • Red Cross War Memorial Childrens Hospital
    • University of Witwatersrand, South Africa
    • University of Zurich
    • Groote Schuur Hospital
    • Nelson Mandela Metropolitan University
    • Chris Hani Baragwanath Academic Hospital
    • University of the Free State

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Ruan Kruger, Professor, North-West University, South Africa
    ClinicalTrials.gov Identifier:
    NCT05982847
    Other Study ID Numbers:
    • REC 4/23/03/22
    First Posted:
    Aug 9, 2023
    Last Update Posted:
    Aug 14, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ruan Kruger, Professor, North-West University, South Africa
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 14, 2023